Ambac Financial Group, Inc. — First Quarter 2024 Form 10-Q
Filing identity: The provided filing is for Ambac Financial Group, Inc. (NYSE: AMBC), not Octave Specialty Group Inc. It covers the three months ended March 31, 2024 and was filed May 6, 2024. Financial statements are unaudited and prepared under U.S. GAAP.
Business context and reporting period
Ambac operates through three segments: Legacy Financial Guarantee Insurance, which has been in runoff since 2008; Specialty Property and Casualty Insurance, primarily Everspan; and Insurance Distribution, including Xchange, All Trans, Capacity Marine and Riverton. The legacy portfolio remains the principal source of financial and regulatory risk, while Specialty P&C and Insurance Distribution are the growth businesses.
Key financial metrics
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Total revenues and other income | $103 million | $58 million | +$45 million |
| Net premiums earned | $33 million | $14 million | +$19 million |
| Commission income | $18 million | $14 million | +$4 million |
| Net investment income | $42 million | $34 million | +$8 million |
| Total expenses | $77 million | $86 million | -$9 million |
| Pretax income (loss) | $26 million | $(29) million | +$55 million |
| Net income (loss) | $21 million | $(33) million | +$54 million |
| Net income attributable to common stockholders | $20 million | $(33) million | +$53 million |
| Diluted EPS | $0.43 | $(0.73) | Improved |
| Operating cash flow | $18 million | $77 million | -$59 million |
| Net cash flow | $21 million | $243 million | -$222 million |
At March 31, 2024, total assets were $8.429 billion, total liabilities were $6.993 billion, and total stockholders’ equity was $1.418 billion, compared with $1.415 billion at December 31, 2023. Ambac Financial Group stockholders’ equity was $1.365 billion, or $30.19 per share. Non-GAAP adjusted book value was $1.313 billion, or $29.03 per share.
Investments totaled $2.682 billion, including $1.687 billion of available-for-sale fixed-maturity securities, $382 million of short-term investments and $558 million of other investments. Cash and cash equivalents were $44 million, including $11 million of restricted cash. Consolidated cash, cash equivalents and restricted cash, including $252 million held by variable interest entities, totaled $296 million.
Reported long-term debt was $512 million, consisting primarily of $495 million of carrying value for surplus notes and $17 million of Ambac UK debt. Accrued interest payable was $487 million. Consolidated variable-interest-entity debt was an additional $2.925 billion, substantially related to financial guarantee structures.
Segment performance and material changes
- Legacy Financial Guarantee Insurance: Pretax income was $25 million versus a $32 million loss in Q1 2023. Results benefited from a $21 million loss benefit, principally from the positive effect of discount rates and assumption changes, compared with $13 million of losses in the prior year. Net investment income increased to $38 million from $31 million.
- Specialty Property and Casualty Insurance: Gross premiums written rose to $96 million from $52 million, and net premiums written increased to $26 million from $9 million. Pretax income was $2 million versus a $1 million loss. The combined ratio improved to 98.4% from 121.9%, although the loss and loss adjustment expense ratio increased to 75.7% from 66.6% as the business expanded and experienced higher commercial auto, excess auto and other liability claims.
- Insurance Distribution: Premiums placed increased 17% to $90 million. Commission income rose to $18 million from $14 million, and pretax income remained $4 million. Growth reflected the Riverton acquisition and organic expansion.
- Financial guarantee exposure: Total net par outstanding declined 2% to $19.031 billion from $19.541 billion. Adversely classified credit exposure declined 21% to $2.776 billion, while watch-list exposure increased 23% to $2.679 billion. Below-investment-grade exposure declined to $2.749 billion from $3.470 billion.
- Reserve position: Gross loss and loss expense reserves declined to $851 million from $893 million. Reserves net of subrogation recoverables and before reinsurance declined to $721 million from $756 million.
- Investing and financing cash flows: Investing activities provided $51 million, while financing activities used $47 million, primarily reflecting $46 million of consolidated VIE debt payments. The prior-year period included a $97 million Tier 2 Note redemption and substantially higher VIE payments.
Liquidity, outlook, risks and unusual items
AFG, the holding company, had $209 million of standalone net assets excluding its operating subsidiaries at March 31, 2024, compared with $211 million at year-end. Management believes current resources are sufficient for near-term holding-company needs, but AFG depends partly on subsidiary distributions and expense reimbursements. Everspan is not expected to pay dividends in the near term, and the ability of AAC to pay dividends remains substantially uncertain.
AAC had $878 million of statutory policyholder surplus and $1.181 billion of qualified statutory capital at March 31, 2024, down from $897 million and $1.201 billion, respectively. AAC’s statutory net loss was $25 million, driven principally by de-risking of student-loan exposures. Ambac UK reported £499 million of shareholder funds and, as of December 31, 2023, £430 million of eligible Solvency II capital against £220 million of regulatory capital requirements.
AAC’s request for regulatory approval to pay principal and interest on surplus notes on June 7, 2024 remained pending as of the filing. The notes had $519 million of principal outstanding and approximately $487 million of accrued unpaid interest at March 31, 2024. The Office of the Commissioner of Insurance may approve or deny payments, and regular interest payments have generally not been approved since issuance.
Management identified significant uncertainty around loss-reserve estimates, credit deterioration, interest rates, foreign exchange, reinsurer credit quality, litigation, regulatory intervention and the ability to realize value from AAC and Ambac UK. Illustrative highest-stress scenarios indicated possible additional losses of approximately $55 million for structured finance, $120 million for public finance and $75 million for other credits, although management stated actual losses could exceed these amounts.
Significant legal matters include the Monterey Bay military housing litigation, National Collegiate Student Loan Trusts litigation and CFPB litigation. On March 19, 2024, the Third Circuit held that the trusts were subject to CFPB enforcement authority and remanded the case for further proceedings. AAC and other intervenors filed a rehearing petition on May 3, 2024. The filing states that material litigation losses are not accrued where they are not probable and reasonably estimable.
The company completed no new share repurchases under its public program during the quarter; 42,016 shares were acquired in March to satisfy employee tax-withholding obligations. The $35 million repurchase authorization expired March 31, 2024.
Most important facts for investors to verify
- Confirm that the intended issuer is Ambac Financial Group, Inc.; the supplied request metadata names a different company.
- Monitor regulatory approval and payment status for AAC’s $519 million of surplus notes and approximately $487 million of accrued interest.
- Assess whether the Q1 reserve benefit is sustainable, particularly the effects of discount rates and assumption changes in the legacy portfolio.
- Track Specialty P&C loss trends, reserve development, pricing adequacy and the 98.4% combined ratio as the business scales.
- Evaluate reinsurance collectability, including $224 million of reinsurance recoverables and $156 million of uncollateralized exposure.
- Review the $19.031 billion legacy financial guarantee exposure, concentrations in the ten largest risks, and the $2.679 billion watch-list portfolio.
- Consider liquidity restrictions and the fact that $252 million of consolidated VIE restricted cash is not directly available for general corporate purposes.
- Follow the CFPB and other litigation proceedings, as adverse outcomes could materially affect reserves, capital and liquidity.